Kansas Administrative Regulations
Agency 28 - DEPARTMENT OF HEALTH AND ENVIRONMENT
Article 21 - FOOD, DRUGS AND COSMETICS
Section 28-21-266 - Special packaging requirements

Universal Citation: KS Admin Regs 28-21-266
Current through Register Vol. 43, No. 12, March 20, 2024

Each vial or ampule of injectable amygdalin and each vial or container of tablets or capsules shall contain a package insert with complete description of the product including potency, adverse reactions, contra-indications, dosage recommendations, mode of administration, and other information as may be required. In packaging amygdalin (laetrile) for direct patient usage, a patient package insert must also be enclosed which summarizes the potential risks of the product. All tablets or capsules shall be packaged in child-proof containers. A precautionary label shall be attached to all packaging of injectable amygdalin (laetrile) warning patients against taking the parenteral preparation by mouth, since the high concentration can be rapidly fatal.

Disclaimer: These regulations may not be the most recent version. Kansas may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.